SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Rakovina Therapeutics to Present ATR Inhibitor Data at Neuro-Oncology Meeting

The company says its poster will highlight AI-designed kt-5000AI compounds developed for PTEN-deficient brain tumours.

Related stories